Protalix Drug Set To Compete In Tough Gaucher Market Via Early Access Scheme

 
• By The Pink Sheet Daily

Both Protalix and Shire stand to benefit from Genzyme's Cerezyme shortage.

More from Archive

More from Pink Sheet